Biospecimen procurement and tissue microarray manufacture for the CHTN

CHTN 的生物样本采购和组织微阵列制造

基本信息

  • 批准号:
    9031568
  • 负责人:
  • 金额:
    $ 59.73万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-04-24 至 2019-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The objectives are to provide users of the Collaborative Human Tissue Network (CHTN) with high quality human tissue and biofluid samples in accordance with NCI Best Practices for biorepositories. Staffing, procedures & infrastructure are in place to minimize procurement times. Tissue samples are quality controlled by histologic examination, with molecular assessment included in a quality assurance program. Specimen procurement at The University of Virginia will be augmented by collection at Eastern Virginia Medical School and the Medical University of South Carolina. Private health information is handled in accordance with Common Rule and HIPAA regulations. To protect subject privacy, all samples are identified only by a code number ("de-identified") and linking codes are maintained in secure databases. Procured tissue specimens are made available in fresh-frozen, chemically-fixed, paraffin-embedded and viable form. Options for viable tissue include frozen cell suspensions of disaggregated solid tissue, small tissue fragments, and viable cells obtained from ascites fluid. In addition to paraffin embedding, histologic sections of paraffn embedded or frozen tissue are offered. Histology-guided macrodissection services are available to investigators who require enriched cell populations. Nucleic acid extraction (RNA and DNA) are offered for both bulk and macrodissected tissue samples. The CHTN tissue microarray (TMA) initiative, currently based in our institution, will continue to be supported and will be expanded. Our ability to provide annotated data is enhanced by integration with a digital Clinical Data Repository at The University of Virginia and with an established tumor registry. During the grant period members of our division will cooperate to integrate local informatic resources with centralized CHTN informatic resources, and to achieve compliance with NCI-mandated bioinformatic standards. Members of our division will support the overall efforts of the CHTN by participating in coordinating meetings and in marketing efforts at scientific meetings. Improvement of the CHTN will be provided by participating in organizational quality management practices and offering leadership in integrating new technological and bio-informatic advances.
描述(由申请人提供):目的是根据NCI生物储存库最佳实践,为协作人体组织网络(CHTN)的用户提供高质量的人体组织和生物流体样本。 人员配备、程序和基础设施到位,以最大限度地缩短采购时间。 组织样本通过组织学检查进行质量控制,分子评估包括在质量保证计划中。 弗吉尼亚大学的标本采购将通过东弗吉尼亚医学院和南卡罗来纳州医科大学的采集来增加。 私人健康信息按照通用规则和HIPAA法规处理。为保护受试者隐私,所有样本仅通过代码编号识别(“去识别”),链接代码保存在安全数据库中。采购的组织标本以新鲜冷冻、化学固定、石蜡包埋和活的形式提供。活组织的选择包括分解的实体组织的冷冻细胞悬浮液、小组织碎片和从腹水中获得的活细胞。除石蜡包埋外,还提供石蜡包埋或冷冻组织的组织切片。组织学引导的宏观解剖服务可用于需要富集细胞群的研究者。核酸提取(RNA和DNA)可用于散装和宏观解剖组织样本。CHTN组织微阵列(TMA)倡议,目前基于我们的机构,将继续得到支持,并将扩大。我们提供注释数据的能力通过与弗吉尼亚大学的数字临床数据库和已建立的肿瘤登记处的集成而得到增强。在资助期间,我们部门的成员将合作整合当地的信息资源与集中的CHTN信息资源,并实现符合NCI规定的生物信息标准。我们部门的成员将通过参加协调会议和科学会议的营销工作来支持CHTN的整体努力。CHTN的改进将通过参与组织质量管理实践和在整合新技术和生物信息学进步方面提供领导来提供。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christopher A. Moskaluk其他文献

Microdissection of histologic sections : manual and laser capture microdissection techniques.
组织切片的显微切割:手动和激光捕获显微切割技术。
  • DOI:
  • 发表时间:
    2001
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Christopher A. Moskaluk
  • 通讯作者:
    Christopher A. Moskaluk
195 - Convolutional Neural Networks Image Analysis of Duodenal Biopsies Robustly Distinguishes Environmental Enteropathy from Healthy Controls and Identifies Secretory Cell Lineages as High Activation Locations
  • DOI:
    10.1016/s0016-5085(18)30638-3
  • 发表时间:
    2018-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Sana Syed;Mohammad Al-Boni;Kamran Sadiq;Najeeha T. Iqbal;Christopher A. Moskaluk;Asad Ali;Sean Moore;Don Brown
  • 通讯作者:
    Don Brown
Interaction of the bovine papillomavirus type 1 E2 transcriptional control protein with the viral enhancer: purification of the DNA-binding domain and analysis of its contact points with DNA
牛乳头瘤病毒 1 型 E2 转录控制蛋白与病毒增强子的相互作用:DNA 结合域的纯化及其与 DNA 的接触点分析
  • DOI:
    10.1128/jvi.62.6.1925-1931.1988
  • 发表时间:
    1988
  • 期刊:
  • 影响因子:
    5.4
  • 作者:
    Christopher A. Moskaluk;Deepak Bastia
  • 通讯作者:
    Deepak Bastia
Su1304 – A Novel Histology Index for Evaluation of Enteropathies Associated with Suboptimal Childhood Growth Identifies Geographic-Specific Features
  • DOI:
    10.1016/s0016-5085(19)38229-0
  • 发表时间:
    2019-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Ta-Chiang Liu;Kelley VanBuskirk;Asad Ali;Paul Kelly;Lori R. Holtz;Christopher A. Moskaluk
  • 通讯作者:
    Christopher A. Moskaluk
Su518 DEEP LEARNING ANALYSIS OF TISSUE EOSINOPHILIA MAY PREDICT TIME TO INITIATE BIOLOGIC THERAPY IN CHILDREN WITH ULCERATIVE COLITIS
  • DOI:
    10.1016/s0016-5085(21)02440-9
  • 发表时间:
    2021-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Aamir Javaid;William Adorno;Philip Fernandes;Eve May;Shyam S. Raghavan;Christopher A. Moskaluk;Donald Brown;Sana Syed
  • 通讯作者:
    Sana Syed

Christopher A. Moskaluk的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christopher A. Moskaluk', 18)}}的其他基金

Biospecimen procurement and tissue microarray manufacture for the CHTN
CHTN 的生物样本采购和组织微阵列制造
  • 批准号:
    10573252
  • 财政年份:
    2019
  • 资助金额:
    $ 59.73万
  • 项目类别:
Biospecimen procurement and tissue microarray manufacture for the CHTN
CHTN 的生物样本采购和组织微阵列制造
  • 批准号:
    9893851
  • 财政年份:
    2019
  • 资助金额:
    $ 59.73万
  • 项目类别:
Biospecimen procurement and tissue microarray manufacture for the CHTN
CHTN 的生物样本采购和组织微阵列制造
  • 批准号:
    10360587
  • 财政年份:
    2019
  • 资助金额:
    $ 59.73万
  • 项目类别:
Biospecimen procurement and tissue microarray manufacture for the CHTN
CHTN 的生物样本采购和组织微阵列制造
  • 批准号:
    8668582
  • 财政年份:
    2014
  • 资助金额:
    $ 59.73万
  • 项目类别:
Molecular characterization of a human salivary gland tumor xenograft bank
人唾液腺肿瘤异种移植库的分子特征
  • 批准号:
    7933897
  • 财政年份:
    2009
  • 资助金额:
    $ 59.73万
  • 项目类别:
Molecular characterization of a human salivary gland tumor xenograft bank
人唾液腺肿瘤异种移植库的分子特征
  • 批准号:
    7837342
  • 财政年份:
    2009
  • 资助金额:
    $ 59.73万
  • 项目类别:
Tumor suppressor gene at 6q in adenoid cystic carcinoma
腺样囊性癌 6q 抑癌基因
  • 批准号:
    6611423
  • 财政年份:
    2002
  • 资助金额:
    $ 59.73万
  • 项目类别:
Tumor suppressor gene at 6q in adenoid cystic carcinoma
腺样囊性癌 6q 抑癌基因
  • 批准号:
    6507300
  • 财政年份:
    2002
  • 资助金额:
    $ 59.73万
  • 项目类别:
Tumor suppressor gene at 6q in adenoid cystic carcinoma
腺样囊性癌 6q 抑癌基因
  • 批准号:
    6747306
  • 财政年份:
    2002
  • 资助金额:
    $ 59.73万
  • 项目类别:
Tumor suppressor gene at 6q in adenoid cystic carcinoma
腺样囊性癌 6q 抑癌基因
  • 批准号:
    7065180
  • 财政年份:
    2002
  • 资助金额:
    $ 59.73万
  • 项目类别:

相似海外基金

Analyses of immune response and bacteria in cirrhotic ascites with Tm mapping method.
Tm 图谱法分析肝硬化腹水中的免疫反应和细菌。
  • 批准号:
    20K08305
  • 财政年份:
    2020
  • 资助金额:
    $ 59.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Randomized controlled trial to elucidate "would patients be weakened if ascites removed?"
随机对照试验阐明“如果腹水被清除,患者会变得虚弱吗?”
  • 批准号:
    20K16567
  • 财政年份:
    2020
  • 资助金额:
    $ 59.73万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of new immuno-cell therapy for the treatment of refractory malignant ascites and pleural effusion
开发新的免疫细胞疗法治疗难治性恶性腹水和胸腔积液
  • 批准号:
    19K09196
  • 财政年份:
    2019
  • 资助金额:
    $ 59.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Ascites proteomics reveal the mechanism of pancreatic cancer peritoneal dissemination
腹水蛋白质组学揭示胰腺癌腹膜播散机制
  • 批准号:
    19K18107
  • 财政年份:
    2019
  • 资助金额:
    $ 59.73万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A Novel Therapy for gastrointestinal cancer targeting exosome in malignant ascites
一种针对恶性腹水中外泌体的胃肠癌新疗法
  • 批准号:
    18H02882
  • 财政年份:
    2018
  • 资助金额:
    $ 59.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Peritoneal metastasis Prediction by exosome in washing ascites for gastric cancer
胃癌洗腹水中外泌体预测腹膜转移
  • 批准号:
    18K16321
  • 财政年份:
    2018
  • 资助金额:
    $ 59.73万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Label-free microfluidic enrichment of cancer cells from noncancer cells in ascites fluid
无标记微流体从腹水中的非癌细胞中富集癌细胞
  • 批准号:
    9251748
  • 财政年份:
    2016
  • 资助金额:
    $ 59.73万
  • 项目类别:
Preparation of ascites purification device for cancerous ascites and establishment of portable continuous ascites purification perfusion method
癌性腹水腹水净化装置的研制及便携式连续腹水净化灌注方法的建立
  • 批准号:
    16K01425
  • 财政年份:
    2016
  • 资助金额:
    $ 59.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Label-free microfluidic enrichment of cancer cells from noncancer cells in ascites fluid
无标记微流体从腹水中的非癌细胞中富集癌细胞
  • 批准号:
    9036692
  • 财政年份:
    2016
  • 资助金额:
    $ 59.73万
  • 项目类别:
Identifying Factors in Malignant Ascites Facilitating Gastric Adenocarcinoma Peritoneal Metastasis
确定恶性腹水促进胃腺癌腹膜转移的因素
  • 批准号:
    349961
  • 财政年份:
    2015
  • 资助金额:
    $ 59.73万
  • 项目类别:
    Studentship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了